UNSPSC 51161710: Calfactant

This classification denotes a respiratory drug, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q4K217VGA9. European Medicines Agency schedules Calfactant in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13207MIG. As of Q4 2014, CALFACTANT remains the US FDA Preferred Term for this commodity.

UNSPSC 51161710 Calfactant is a Commodity code that in practice encompasses pharmaceutical products and pharmacy services that state and local governments procure to support public health initiatives and employee health benefits. The recent opportunities under this code reflect a broader pattern than the narrow drug name suggests: Seminole County, Florida solicited naloxone and drug deactivation systems for community health support, while Hall County, Georgia sought a comprehensive on-site pharmacy services provider to manage formulary dispensing and medication management for county employees and retirees. Both solicitations target the underlying function — ensuring reliable pharmaceutical access — rather than a single product line. Issuing bodies include county health departments and county government human resources functions. Neither opportunity flagged set-aside designations, and both required E-Verify compliance and standard insurance coverage.

Seminole County issued IFB 60459723LAS in June 2026 for annual procurement of 1,900 units of naloxone and 800 drug deactivation systems with quarterly delivery to the county health building and a response deadline of July 26, 2023, while Hall County issued RFQ/P #47-010 in May 2026 for on-site pharmacy services at a family health center clinic in Gainesville, Georgia, supporting approximately 3,005 eligible plan members across multiple insurance products, with responses due June 4, 2026. The Hall County contract employs an 80/20 scoring structure favoring technical qualifications over cost and requires vendors to stock and dispense a specified formulary of 25 medications. Recent activity clusters in Florida and Georgia, though the sample size is limited and the code shows sparse recent solicitation volume across state and local jurisdictions.